Risk of cardiovascular disease in patients with multiple sclerosis treated with fingolimod compared to natalizumab: A nationwide cohort study of 2095 patients in DenmarkElisabeth Framke, Melinda Magyari, Lau Caspar Thygesen et al.|Multiple Sclerosis Journal|2024Cited by 10
Rebound of clinical disease activity after fingolimod discontinuation? A nationwide cohort study of patients in DenmarkElisabeth Framke, Melinda Magyari, Stephan Bramow et al.|Journal of Neurology Neurosurgery & Psychiatry|2022Cited by 9
<scp>COVID</scp>‐19 vaccination and relapse activity: A nationwide cohort study of patients with multiple sclerosis in DenmarkDominika Šťastná, Melinda Magyari, Jiří Drahota et al.|European Journal of Neurology|2023Cited by 6
Allopurinol use and risk of multiple sclerosisIda M. Heerfordt, Henrik Horwitz, Elisabeth Framke et al.|Multiple Sclerosis and Related Disorders|2025Cited by 4
Interferon-beta exposure in-utero and the risk of infections in early childhoodJosefine Windfeld‐Mathiasen, Melinda Magyari, Henrik Horwitz et al.|Multiple Sclerosis and Related Disorders|2023Cited by 3